<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is associated with production of autoantibodies </plain></SENT>
<SENT sid="1" pm="."><plain>The N-terminal 35-58 sequence of EBNA I, one of the nuclear antigens encoded by EBV, is highly homologous to the C-terminal 95-119 region of the ribonucleoprotein SmD </plain></SENT>
<SENT sid="2" pm="."><plain>Autoantibodies specific for SmD are present only in systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> (SLE) sera and are therefore considered a serological marker of SLE </plain></SENT>
<SENT sid="3" pm="."><plain>We measured antibodies to the EBNA I 35-58 sequence in EBV-related diseases and in <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Antibodies to the EBNA I 35-58 peptide were present in 30% of <z:mpath ids='MPATH_458'>normal</z:mpath> sera, 12% Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 22% <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, 25% <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, 38% SLE and 33% <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sjogren's syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Antibodies to the SmD 95-119 peptide were detectable in 32% of SLE sera, 17% <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> and 12% Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The specificity of anti-EBNA I 35-58 antibodies affinity-purified from nine sera was analysed by means of an inhibition assay </plain></SENT>
<SENT sid="7" pm="."><plain>Only anti-EBNA I 35-58 antibodies affinity-purified from SLE sera have a similar affinity for the <z:mp ids='MP_0001799'>viral</z:mp> <z:chebi fb="7" ids="16670">peptide</z:chebi> and the SmD C-terminal one; they also bind the recombinant SmD in western blot </plain></SENT>
<SENT sid="8" pm="."><plain>The results indicate that antibodies to EBNA I 35-58 are produced in <z:mpath ids='MPATH_458'>normals</z:mpath>, in EBV-related diseases and in <z:e sem="disease" ids="C0004364" disease_type="Disease or Syndrome" abbrv="">autoimmune disorder</z:e>, but only SLE sera contain anti-<z:mp ids='MP_0001799'>viral</z:mp> antibodies cross-reactive with an autoantigen </plain></SENT>
</text></document>